Vaccine manufacturers in India are planning to ramp up production after the government announced liberalising of the procurement process and making everyone above the age of 18 eligible for jabs. The supply of jabs is expected to increase from June, according to Economic Times report.
In a meeting with PM Narendra Modi on Tuesday, vaccine makers were told to increase production capacity. Adar Poonawalla’s Serum Institute of India (SII) is expected to increase production by May with an increase in production capacity.
By June supply of jabs in India is expected to increase upto 200 million with an increase in production from SII and Bharat Biotech and taking into account imports from Sputnik. It currently stands at 70 million.
The government also asked states and private hospitals to negotiate prices with vaccine makers. The manufacturers in turn have requested the government to price jabs to make them globally competitive.
Bharat Biotech on Tuesday said it will increase production to 700 million Covid-19 vials and plans to export the vaccine to 60 countries. It kept a price of $15-20 vial for the international market.
On average in India, vaccine doses are likely to be priced between Rs 500-1,000 per vial, the ET report said quoting sources. This will be maximum retail price including true margin and manufacturers will make around Rs 650 per dose.
Vaccine makers will need to declare the price of vaccines as they will supply to market including private hospitals and industries.
The Indian government has been procuring vaccines at low prices so far. AstraZeneca’s Covid-19 shot is procured at low prices so far. The same dose sells for $3-6 globally.
Phase 3 of the National Vaccine Strategy, would come in effect from May 1, 2021. Under the same,vaccine manufacturers would supply 50% of their monthly Central Drugs Laboratory (CDL) released doses to the central government and would be free to supply the remaining 50% doses to state governments and in the open market.
Manufacturers would transparently make an advance declaration of the price for 50% supply that would be available to state governments and in open market before May 1, 2021. Based on this price, state governments, private hospitals, industrial establishments etc would be able to procure vaccine doses from the manufacturers.
Private vaccination providers shall transparently declare their self-set vaccination price. The eligibility through this channel would be opened up to all adults, i.e. everyone above the age of 18.